Cargando…

Development of Epirubicin-Loaded Biocompatible Polymer PLA–PEG–PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment

Epirubicin (EPI) is an anti-cancerous chemotherapeutic drug that is an effective epimer of doxorubicin with less cardiotoxicity. Although EPI has fewer side effects than its analog, doxorubicin, this study aims to develop EPI nanoparticles as an improved formula of the conventional treatment of EPI...

Descripción completa

Detalles Bibliográficos
Autores principales: Massadeh, Salam, Almohammed, Iman, Barhoush, Eman, Omer, Mustafa, Aldhawi, Nouf, Almalik, Abdulaziz, Alaamery, Manal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070301/
https://www.ncbi.nlm.nih.gov/pubmed/33918625
http://dx.doi.org/10.3390/polym13081212
_version_ 1783683438380843008
author Massadeh, Salam
Almohammed, Iman
Barhoush, Eman
Omer, Mustafa
Aldhawi, Nouf
Almalik, Abdulaziz
Alaamery, Manal
author_facet Massadeh, Salam
Almohammed, Iman
Barhoush, Eman
Omer, Mustafa
Aldhawi, Nouf
Almalik, Abdulaziz
Alaamery, Manal
author_sort Massadeh, Salam
collection PubMed
description Epirubicin (EPI) is an anti-cancerous chemotherapeutic drug that is an effective epimer of doxorubicin with less cardiotoxicity. Although EPI has fewer side effects than its analog, doxorubicin, this study aims to develop EPI nanoparticles as an improved formula of the conventional treatment of EPI in its free form. Methods: In this study, EPI-loaded polymeric nanoparticles (EPI-NPs) were prepared by the double emulsion method using a biocompatible poly (lactide) poly (ethylene glycol) poly(lactide) (PLA–PEG–PLA) polymer. The physicochemical properties of the EPI-NPs were determined by dynamic light scattering (DLS), transmission electron microscopy (TEM), differential scanning calorimetry (DSC), entrapment efficiency and stability studies. The effect of EPI-NPs on cancer cells was determined by high throughput imaging and flow cytometry. Results: The synthesis process resulted in monodisperse EPI-NPs with a size of 166.93 ± 1.40 nm and an elevated encapsulation efficiency (EE) of 88.3%. In addition, TEM images revealed the spherical uniformness of EPI-NPs with no aggregation, while the cellular studies presented the effect of EPI-NPs on MCF-7 cells’ viability; after 96 h of treatment, the MCF-7 cells presented considerable apoptotic activity. The stability study showed that the EPI-NPs remained stable at room temperature at physiological pH for over 30 days. Conclusion: EPI-NPs were successfully encapsulated within a highly stable biocompatible polymer with minimal loss of the drug. The used polymer has low cytotoxicity and EPI-NPs induced apoptosis in estrogen-positive cell line, making them a promising, safe treatment for cancer with less adverse side effects.
format Online
Article
Text
id pubmed-8070301
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80703012021-04-26 Development of Epirubicin-Loaded Biocompatible Polymer PLA–PEG–PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment Massadeh, Salam Almohammed, Iman Barhoush, Eman Omer, Mustafa Aldhawi, Nouf Almalik, Abdulaziz Alaamery, Manal Polymers (Basel) Article Epirubicin (EPI) is an anti-cancerous chemotherapeutic drug that is an effective epimer of doxorubicin with less cardiotoxicity. Although EPI has fewer side effects than its analog, doxorubicin, this study aims to develop EPI nanoparticles as an improved formula of the conventional treatment of EPI in its free form. Methods: In this study, EPI-loaded polymeric nanoparticles (EPI-NPs) were prepared by the double emulsion method using a biocompatible poly (lactide) poly (ethylene glycol) poly(lactide) (PLA–PEG–PLA) polymer. The physicochemical properties of the EPI-NPs were determined by dynamic light scattering (DLS), transmission electron microscopy (TEM), differential scanning calorimetry (DSC), entrapment efficiency and stability studies. The effect of EPI-NPs on cancer cells was determined by high throughput imaging and flow cytometry. Results: The synthesis process resulted in monodisperse EPI-NPs with a size of 166.93 ± 1.40 nm and an elevated encapsulation efficiency (EE) of 88.3%. In addition, TEM images revealed the spherical uniformness of EPI-NPs with no aggregation, while the cellular studies presented the effect of EPI-NPs on MCF-7 cells’ viability; after 96 h of treatment, the MCF-7 cells presented considerable apoptotic activity. The stability study showed that the EPI-NPs remained stable at room temperature at physiological pH for over 30 days. Conclusion: EPI-NPs were successfully encapsulated within a highly stable biocompatible polymer with minimal loss of the drug. The used polymer has low cytotoxicity and EPI-NPs induced apoptosis in estrogen-positive cell line, making them a promising, safe treatment for cancer with less adverse side effects. MDPI 2021-04-09 /pmc/articles/PMC8070301/ /pubmed/33918625 http://dx.doi.org/10.3390/polym13081212 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Massadeh, Salam
Almohammed, Iman
Barhoush, Eman
Omer, Mustafa
Aldhawi, Nouf
Almalik, Abdulaziz
Alaamery, Manal
Development of Epirubicin-Loaded Biocompatible Polymer PLA–PEG–PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment
title Development of Epirubicin-Loaded Biocompatible Polymer PLA–PEG–PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment
title_full Development of Epirubicin-Loaded Biocompatible Polymer PLA–PEG–PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment
title_fullStr Development of Epirubicin-Loaded Biocompatible Polymer PLA–PEG–PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment
title_full_unstemmed Development of Epirubicin-Loaded Biocompatible Polymer PLA–PEG–PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment
title_short Development of Epirubicin-Loaded Biocompatible Polymer PLA–PEG–PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment
title_sort development of epirubicin-loaded biocompatible polymer pla–peg–pla nanoparticles: synthesis, characterization, stability, and in vitro anticancerous assessment
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070301/
https://www.ncbi.nlm.nih.gov/pubmed/33918625
http://dx.doi.org/10.3390/polym13081212
work_keys_str_mv AT massadehsalam developmentofepirubicinloadedbiocompatiblepolymerplapegplananoparticlessynthesischaracterizationstabilityandinvitroanticancerousassessment
AT almohammediman developmentofepirubicinloadedbiocompatiblepolymerplapegplananoparticlessynthesischaracterizationstabilityandinvitroanticancerousassessment
AT barhousheman developmentofepirubicinloadedbiocompatiblepolymerplapegplananoparticlessynthesischaracterizationstabilityandinvitroanticancerousassessment
AT omermustafa developmentofepirubicinloadedbiocompatiblepolymerplapegplananoparticlessynthesischaracterizationstabilityandinvitroanticancerousassessment
AT aldhawinouf developmentofepirubicinloadedbiocompatiblepolymerplapegplananoparticlessynthesischaracterizationstabilityandinvitroanticancerousassessment
AT almalikabdulaziz developmentofepirubicinloadedbiocompatiblepolymerplapegplananoparticlessynthesischaracterizationstabilityandinvitroanticancerousassessment
AT alaamerymanal developmentofepirubicinloadedbiocompatiblepolymerplapegplananoparticlessynthesischaracterizationstabilityandinvitroanticancerousassessment